Killing Targeted Bacteria With CRISPR Drugs Is SNIPR BIOME's Promise

CEO Says Danish Biotech Wants To Soon Raise $100-$150m

 
• By Sten Stovall
  
SNIPR BIOME's first candidate will target only E. coli bacteria in the gut • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D